LAMA5
Overview
LAMA5 encodes laminin subunit alpha 5, a large extracellular matrix glycoprotein and component of basement membrane laminins. Laminins mediate cell adhesion, migration, and signaling. High-level somatic copy-number amplification of LAMA5 has been reported in cutaneous squamous cell carcinoma, where it represents the most recurrently high-level amplified candidate oncogene.
Alterations observed in the corpus
- LAMA5 is the most recurrently high-level amplified oncogene in metastatic cSCC (4/29 samples with high-level amplification), identified by GISTIC analysis of targeted sequencing data (OncoPanelv2, 504 genes) from 29 lymph-node metastases. PMID:25589618
Cancer types (linked)
- CSCC: High-level copy-number amplification in 4/29 (14%) metastatic cSCC lymph-node metastases; the biological significance and mechanism are not yet established. PMID:25589618
Co-occurrence and mutual exclusivity
- Co-amplified with MYC, TP63, CCND1, and EGFR in the recurrent copy-number gain landscape of metastatic cSCC. PMID:25589618
Therapeutic relevance
- No therapeutic associations reported. PMID:25589618
Open questions
- Whether LAMA5 amplification drives oncogenic signaling or is a passenger event within a broader amplicon requires functional validation. PMID:25589618
Sources
This page was processed by crosslinker on 2026-05-14.